Terms: = Kidney tumors AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Clinical Outcome
3 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. [Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma].
Hong YP; Yao XD; Zhu Y; Ye DW; Shi GH; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu YP; Ma CG; Xiao WJ; Qin XJ; Lin GW
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2880-3. PubMed ID: 24373400
[TBL] [Abstract] [Full Text] [Related]
3. Quantification of angiogenesis by a computerized image analysis system in renal cell carcinoma.
Lee JS; Jung JJ; Kim J
Anal Quant Cytol Histol; 2000 Dec; 22(6):469-74. PubMed ID: 11147301
[TBL] [Abstract] [Full Text] [Related]
